28 January 2004

Alzheimer's Disease: 60% Reduction in Risk From Eating Fish Once a Week!

About 50% of existing disease can be avoided by nutritional strategies. One of the easiest to avoid is Alzheimer's disease by eating fish once a week. Better yet, use pharmaceutical fish oil every day and protect your heart as well as your brain. Vitamin C and E in combination reduce the risk even further, but that is another paper.

Has your doctor told you this? Probably not. Surveys show that most cardiologists take Vitamin E and few ever tell their patients. I suspect neurologists are about the same. Is that malpractice? You decide.

Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease
Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, Aggarwal N, Schneider J.
Arch Neurol. 2003 Jul;60(7):923-4.

BACKGROUND: Dietary n-3 polyunsaturated fatty acids improve brain functioning in animal studies, but there is limited study of whether this type of fat protects against Alzheimer disease.
OBJECTIVE: To examine whether fish consumption and intake of different types of n-3 fatty acids protect against Alzheimer disease.
DESIGN: Prospective study conducted from 1993 through 2000, of a stratified random sample from a geographically defined community. Participants were followed up for an average of 3.9 years for the development of Alzheimer disease.
PATIENTS: A total of 815 residents, aged 65 to 94 years, who were initially unaffected by Alzheimer disease and completed a dietary questionnaire on average 2.3 years before clinical evaluation of incident disease.
MAIN OUTCOME MEASURES: Incident Alzheimer disease diagnosed in a structured neurologic examination by means of standardized criteria.
RESULTS: A total of 131 sample participants developed Alzheimer disease. Participants who consumed fish once per week or more had 60% less risk of Alzheimer disease compared with those who rarely or never ate fish (relative risk, 0.4; 95% confidence interval, 0.2-0.9) in a model adjusted for age and other risk factors. Total intake of n-3 polyunsaturated fatty acids was associated with reduced risk of Alzheimer disease, as was intake of docosahexaenoic acid (22:6n-3). Eicosapentaenoic acid (20:5n-3) was not associated with Alzheimer disease. The associations remained unchanged with additional adjustment for intakes of other dietary fats and of vitamin E and for cardiovascular conditions.
CONCLUSION: Dietary intake of n-3 fatty acids and weekly consumption of fish may reduce the risk of incident Alzheimer disease.

27 January 2004

Nobel Laureates: Better to Be "Wacko" than Good

I often get email from people interested in frequency medicine that are called "wacko" by their spouse, their physicians, and their friends. On occassion, I even get called "wacko" myself, although that is becoming increasingly rare as people, including clinicians, get consistent results based on comments posted here.

My favorite mentor and "wacko" is Linus Pauling who was sponsor of the Center for Vitamins and Cancer Research that I cofounded at the University of Colorado School of Medicine in 1980. Linus only won two Nobel Prizes and was very upset he did not get a third for discovering DNA. He loaned some data to Watson and Crick and they got the jump on him, maybe because of Linus's data. The government thought he was really "wacko" for winning a Nobel Prize for complaining about nuclear testing hazards, considered him a security risk, and would not let him out of the country. The Chinese felt the same way about the Dalai Lama when he got the Nobel Peace Prize.

Francis Crick was a "wacko" of sorts because he was a physicist who dabbled in biology.

Let's take a look at the "wacko" of the week in today's Investor's Business Daily, not exactly a "wacko" publication. J. Michael Bishop won the Noble Prize in 1989 for discovering that normal genes cause cancer. Most of todays clinicians still do not get it. Normal programming in a cell is turned on to produce cancer. We have to turn the program off, not blast cells with various technologies that risk the patients life.

Researcher J. Michael Bishop - Have Vision: Following his instincts helped this doctor win a Nobel Prize
Curt Schleier, Investor's Business Daily, 27 Jan 2004

Bishop had an idea for a research project early in his career. He wanted to research a theory by Dr. Howard Temin of the University of Wisconsin that retroviruses let genetic information flow backward through what was then though of as one-way circuitry in a cell. However, many of Bishop's peers predicted his work was doomed to fail. Instead of following his instincts, he listened and abandoned the research, only to discover a year later that Temin and others succeeded where he'd feared to go.

"If you have an idea that you think is really good -- particularly if it's path-breaking -- shut off your antennae and just go with it," Bishop said. "If your own judgment about these things is not sound, your're not going to make it as a scientist. You'd rather find that out sooner than later..."

Bishop says one reason so many scientists were skeptical about Temin's theory was its source, at an unlikely outpost in Wisconsin. It taught Bishop to judge ideas on merit -- not where they originate.

"Howard Temin had a good pedigree, but he was working at the University of Wisconsin," Bishop said. "There he was making this heretical proposal on how retroviruses replicate. I saw him at one of the first scientific meetings I attended. He was literally denigrated by the chair of the session in advance of his talk, accused of being a wacko. (Temin) was right, but it was clear that people were willing to snipe at him because he wasn't from Harvard or MIT."

So the next time your spouse, your physician, or your friends call you wacko, thank them! You may be in good company.

24 January 2004

EM FAQ: What Frequency Device Should I Use to Kill Pathogens?

I started this web site as an FSCAN FAQ, answers to frequently asked questions about the FSCAN. After working with hundreds of people using many different types of devices, I need an Electronic Medicine FAQ or an ElectroMagnetic device FAQ, or EM FAQ.

Various people have asked me a lot of questions this week and even to write a book. For now, the web site will have to do. I’ll try to accumulate information in a form that can be used to create a book in the future. Meanwhile, here are a couple of frequently asked questions that were asked again this week.

Does it matter what frequency device I use?

The simple answer is no. If you can select an exact frequency for a pathogen and get energy transfer at that frequency to the pathogen, the device doesn’t matter. Some enthusiasts are on an endless search for the magic bullet device that will make them successful. Some are trying to recreate the device that Rife used successfully. I don’t think that will solve the problem. Any good frequency generator can work.

That said, if your device puts out a well formed square wave, you will get better results. If it is a pad device you need positive DC offset. It is very useful to be able to add a gating or pulsing frequency to the primary frequency. In addition, being able to control the duty cycle of the device or the percent time the waveform is above zero volts is important, particularly for certain organisms. These factors can shorten treatment time from hours to minutes or seconds if used properly.

It is extremely useful to be able to program all these parameters in a simple scripting language that precisely articulates the treatment pattern which is why the F100 series devices are commonly used to drive EMEM plasma systems.

Getting energy transfer to the target organism is essential to success. The relative utility of emitting frequencies via pads, handheld electrodes, magnetic devices, plasma tubes, is largely related to the ability to penetrate the body to hit pathogens in internal organs. A handheld electrode will generate an effective magnetic field about one inch from the electrode, while a magnetic pad will penetrate several inches. A powerful EMEM device will fill an entire room with an electromagnetic field. An Advanced BioPhoton Analyzer transmits independent of distance and will penetrate every cell in the body.

Power transfer to the pathogy is critical. Low power may annoy it where higher power will kill it. For some organisms in some internal organs, you will never get enough power transfer with a pad device without plate zapping using microscopic slides of target tissue. Plate zapping is possible with any device, including plasma devices.

Pad or handheld electrode devices like the FSCAN2 or F100 series devices used stand alone are best for initial use. EMEM devices are powerful devices that are best used by people with some expertise. I don’t like exposure to radio frequency fields and avoid RF devices, so I use Bruce Stenulson’s EM devices which do not emit RF fields.

All of this said, what really matters is the ability to detect exact frequencies within a few hertz for specific pathogens. Without the exact frequency, success will be sporadic at best, no matter what device you use. I believe this is what made Rife successful. He actually did not understand much about frequencies, nor did he have the accurate, solid state devices we now use for frequency generators. What he did have was a powerful microscope that allowed him to see pathogens self-destruct when he tuned his plasma device to the right setting. In this way he got the exact frequency. Attempts to reproduce his device without the exact frequencies will not meet with success.

If I just run all the Rife frequency sets that I find on the Internet, will I solve my problem?

To me, this question is like asking if I take a shotgun and shoot it in random directions, will I kill something that is bothering me? Some people are building powerful devices that do this automatically. The answer is yes, maybe, but there will be collateral damage.

Electromagnetic fields can effect cells positively or negatively. There is plenty of research that show, for example, that cell phones negatively affect cell function, and this can be clearly seen in blood analysis. I try to minimize my exposure to my cell phone and minimize my exposure to frequency devices.

The best approach is to identify the specific target organism, the specific location of the organism, and, like an expert marksman, fire one shot that eliminates the target without affecting anything else.
Click here for comments and clarifications

23 January 2004

Emerging BioTech: Great Opportunities for Electronic Medicine

New biotech directions provide significant opportunity for electronic medicine. The article below focuses on altering genes to stop replication of AIDs virus, cancer cells, and so forth. However, the genes simply stop creation of proteins and electromagnetic fields can eliminate these same proteins.

In future years, researchers will find that genetic engineering can be accomplished more easily with electromagnetic fields. Meanwhile, electromedicine researchers can focus on identifying specific proteins causing health problems and knock them out with a frequency device.

RNAi Therapy
Thomas Tuschl
10 Emerging Technologies That Will Change Your World
MIT Technology Review, February 2004

From heart disease to hepatitis, cancer to AIDS, a host of modern ailments are triggered by our own errant genes—or by those of invading organisms. So if a simple technique could be found for turning off specific genes at will, these diseases could—in theory—be arrested or cured. Biochemist Thomas Tuschl may have found just such an off switch in humans: RNA interference (RNAi). While working at Germany’s Max Planck Institute for Biophysical Chemistry, Tuschl discovered that tiny double-stranded molecules of RNA designed to target a certain gene can, when introduced into human cells, specifically block that gene’s effects.

22 January 2004

Freud Gets a Reprieve: Memory Suppression Has Biological Mechanism

Psychologists offer proof of brain’s ability to suppress memories
BY Lisa Trei
Stanford Report, Jan. 8, 2004

For the first time, researchers at Stanford University and the University of Oregon have shown that a biological mechanism exists in the human brain to block unwanted memories.

The findings, published Jan. 9 in the journal Science, reinforce Sigmund Freud's controversial century-old thesis about the existence of voluntary memory suppression.

"The big news is that we've shown how the human brain blocks an unwanted memory, that there is such a mechanism and it has a biological basis," said Stanford psychology Professor John Gabrieli, a co-author of the paper titled "Neural Systems Underlying the Suppression of Unwanted Memories." "It gets you past the possibility that there's nothing in the brain that would suppress a memory -- that it was all a misunderstood fiction."

The experiment showed that people are capable of repeatedly blocking thoughts of experiences they don't want to remember until they can no longer retrieve the memory, even if they want to, Gabrieli explained.

16 January 2004

Genetic Engineering Causes Antibiotic Resistance Pathogens

One of the primary reasons for my interest in electronic medicine is simply to protect family and friends from the day when antibiotics become useless due to ignorance, apathy, and business driven imperatives. That day may come sooner than we expect due to the way genetic engineering is done. It is not that genetic engineering is bad, it is that it is used in ways that are designed to produce antibiotic resistance strains. Charlotte Boehme reports on this in the Rife Forum.

For a long time I have been reading that somehow, genetic engineering can cause bacterial resistance to antibiotics - but never quite understood exactly how or why.  This week I came across an article that explains it quite clearly.  The problem originates in the manufacturing process and goes something like this...

- at the beginning stage of modifying the DNA of the target cells, the cells don't easily uptake the material that the people want inserted into the genome.  The article states that "fewer than 1 in every 1000 or even 1 in every 100,000 cells is modified during the process itself."  In
other words, it's the exception rather than the rule when they get a "take-up" by a cell.

- in order to identify which cells had a good takeup of the genetically modified material, in most instances they include in the GM material a gene that codes for antibiotic resistance.  So not only is the desired new trait going into a cell, but also antibiotic resistance.

- initially, all the cells with or without a "take" are cultured, but the the culture media itself contains an antibiotic.  Thus the cells with no "take-up" of genetically modified material are killed off, and only the cells with a "take" survive the culture conditions.  The antibiotic provides the necessary selection for the manufacturing process.

- the antibiotic resistance gene makes its way - along with the other GM material - into the future plant material, is eaten by animals, gets into the digestive tract and perhaps other areas of the body.  The DNA for the antibiotic resistance can then be transmitted into the DNA of the bacteria within the body (this process is called "horizontal transmission" and is well-documented).  The antibiotic resistance gene(s) may also make their way into other areas of the environment.

Considering these things, one is forced to wonder whether the outbreaks of severely pathogenic bacteria in the meat supply are being supported by the presence of the antibiotic resistance gene(s) in the animals' food supply.  And whether our policy makers are truly aware of this problem.

The entire article mentioned above by Dr. Narash Harang, is easy to understand and worth the read ... with the full article being at

Charlotte Boehme
Rife Forum

13 January 2004

Vitamin D Intake Related to 40% Reduction in Risk of Multiple Sclerosis

Vitamin D intake and incidence of multiple sclerosis
K. L. Munger, MSc, S. M. Zhang, MD ScD, E. O’Reilly, MSc, M. A. HernĂ¡n, MD DrPH, M. J. Olek, DO, W. C. Willett, MD DrPH and A. Ascherio, MD DrPH
NEUROLOGY 2004;62:60-65

Background: A protective effect of vitamin D on risk of multiple sclerosis (MS) has been proposed, but no prospective studies have addressed this hypothesis.
Methods: Dietary vitamin D intake was examined directly in relation to risk of MS in two large cohorts of women: the Nurses’ Health Study (NHS; 92,253 women followed from 1980 to 2000) and Nurses’ Health Study II (NHS II; 95,310 women followed from 1991 to 2001). Diet was assessed at baseline and updated every 4 years thereafter. During the follow-up, 173 cases of MS with onset of symptoms after baseline were confirmed.
Results: The pooled age-adjusted relative risk (RR) comparing women in the highest quintile of total vitamin D intake at baseline with those in the lowest was 0.67 (95% CI = 0.40 to 1.12; p for trend = 0.03). Intake of vitamin D from supplements was also inversely associated with risk of MS; the RR comparing women with intake of DER="0">400 IU/day with women with no supplemental vitamin D intake was 0.59 (95% CI = 0.38 to 0.91; p for trend = 0.006). No association was found between vitamin D from food and MS incidence.
Conclusion: These results support a protective effect of vitamin D intake on risk of developing MS.

11 January 2004

Researchers use Rife cancer germ to produce enzyme that degrades Mad Cow disease prions

The EPA has chosen not to regulate Bacillus licheniformus, which was recently identified by British researchers as the Rife "cancer germ" through DNA sequencing of multiple pleomorphic forms of this organism. This organism appears to be a mutagen and tumor promoter, is sold in many probiotic nutritional products, and is extremely hazardous. Eliminating this organism is the first step in dealing with any form of cancer and it appears in virtually all cancer patients. This is documented extensively in my archives.

Fortunately, the researchers have isolated the enzyme produced by Bacillus licheniformus that degrades Mad Cow prions. Unfortunately, the ignorant may promote putting Bacillus licheniformus in animal feed and expose us to signficantly increased risk of cancer. I strongly recommend you avoid any food that may be contaminated by Baccilus licheniformus. I've found this in animal meats, certain oils, as well as in probiotic supplements. Fortunately, in the case of some probiotics, they list it on the package as an ingredient, so the knowledgeable can avoid this hazard in some cases.

It would be interesting to followup these researchers over the years as they may have infected themselves with Bacillus Licheniformus and be at high risk of developing cancer.

Enzymatic degradation of prion protein in brain stem from infected cattle and sheep
Langeveld JP, Wang JJ, Van de Wiel DF, Shih GC, Garssen GJ, Bossers A, Shih JC.
J Infect Dis. 2003 Dec 1;188(11):1782-9.

Prions-infectious agents involved in transmissible spongiform encephalopathies-normally survive proteolytic and mild protein-destructive processes. Using bacterial keratinase produced by Bacillus licheniformis strain PWD-1, we tested conditions to accomplish the full degradation of prion protein (PrP) in brain-stem tissue from animals with bovine spongiform encephalopathy and scrapie. The detection of PrPSc, the disease-associated isoform of PrP, in homogenates was done by Western blotting and various antibodies. The results indicated that only in the presence of detergents did heat pretreatment at >100 degrees C allow the extensive enzymatic breakdown of PrPSc to a state where it is immunochemically undetectable. Proteinase K and 2 other subtilisin proteases, but not trypsin and pepsin, were also effective. This enzymatic process could lead to the development of a method for the decontamination of medical and laboratory equipment. The ultimate effectiveness of this method of prion inactivation has to be tested in mouse bioassays.

Click here for updates and comments

05 January 2004

Patient Safety: A Nobel Prize for Medicine?

The revolutionary
Donald Berwick says our nation's world-class hospitals and doctors are delivering health care that is unsafe and unreliable. But his call to dismantle the system makes the medical establishment uneasy -- especially since he used to be part of it.
By Neil Swidey, Globe Staff, 1/4/2004

... Every year, up to 98,000 people are believed to die in American hospitals because of medical mistakes. The studies that provided the basis for that chilling estimate were not Berwick's, yet no one has done more to ensure that the findings remain at the top of the national health care agenda. And Berwick is committed to doing more than just sounding alarms. He believes health care can be dramatically improved if it takes to heart the systems-improvement work that has transformed other industries, and if it focuses on eliminating the danger, waste, confusion, and arrogance that are pulling medicine down. He and his institute are working with several hundred health care organizations, large and small, in an effort to post results that would back up his theories. The swelling ranks of Berwick's acolytes speak of him in almost messianic terms. "Don Berwick should win the Nobel Prize for Medicine," says Blair Sadler, who runs San Diego Children's Hospital. "I think he has saved more lives than any doctor alive today."

But the deeper Berwick has gotten into the problem over the last decade, the more radicalized he has become. At this point, mild-mannered, soft-spoken, self-effacing 57-year-old Don Berwick can best be described as a revolutionary. A lot of people say the current health care system is broken, but by that they mean the manner of financing it. Berwick gets irritated when health care leaders complain about a lack of resources. There's too much money in the system already, he says. His critique takes aim at the medical profession's exalted view of itself. He's convinced that the fundamentals of the current system -- the same fundamentals Boston used to build its reputation as the world's medical leader -- are so screwed up that it is no longer possible for the medical profession to provide reliable, high-quality care, no matter how many innovations its renowned doctors roll out, no matter how many awards they rack up. "They want to cure cancer," Berwick says. "Well, how about curing health care?"

His conclusion: To save the health care system, it first needs to be blown up.

his is what health care would look like if Don Berwick ruled the world, rather than just traveled it:

When you wanted to see your doctor, you would call in the morning and get an appointment that afternoon. And it would start on time, not an hour and three outdated People magazines later.

You would maintain control of your medical record, rather than needing a subpoena just to get a peek at it.

Hospitals would have genuine one-stop registration, and every employee would be trained to have the customer-service touch of a Ritz-Carlton concierge. No one would ask you to wear one of those open-backed johnnies.

Waiting would be kept to a minimum, because the hospital will have embraced flow management, anticipating rather than just reacting. There would be no visiting hours in the intensive care unit, since any family member could visit at any time.

Medication errors -- overdoses, allergic reactions, and other adverse responses -- would be all but eliminated by the universal adoption of computerized drug-ordering systems. Hospitals would impose a zero-tolerance policy for workers failing to wash their hands, a move that could save upward of 10,000 lives a year.

Communication and patient-advocacy systems would put an end to horror stories like the one involving the 5-year-old boy who died at Children's Hospital last year because each of his many doctors assumed another doctor was in charge.

Waste would be systematically reduced. Hospital performance would become so transparent that finding the best place to get an operation would be almost as easy as shopping for a new TV online.

And the treatment you receive from your doctors would be made far more effective by a system that gave them less discretion. Physician habit and ego would take a back seat to science in determining standardized courses of medical action. Berwick argues that in terms of improving safety, health care could learn a lot from aviation, where commercial pilots have much less discretion than they used to.

Medical Error: How to Reduce It

Electronic medicine takes many forms. Information at the point of care can radically reduce medical error, the third leading cause of death in the United States. The largest component of medical error is caused by medication error, by itself the fourth leading cause of death. Computer Physician Order Entry (CPOE) can reduce medication error by over 95% in pediatric critical care units. Currently, only about 6% of healthcare institutions use these systems in the U.S. and only a small fraction of those have more than 50% of physicians actually using CPOE.

PEDIATRICS Vol. 113 No. 1 January 2004, pp. 59-63
Computerized Physician Order Entry and Medication Errors in a Pediatric Critical Care Unit
Amy L. Potts, PharmD, Frederick E. Barr, MD, MSCI, David F. Gregory, PharmD, BCPS, Lorianne Wright, PharmD and Neal R. Patel, MD, MPH

Objective. Medication errors are a major concern of health care professionals and medical institutions, especially errors involving children. Studies in adults have shown that computerized physician order entry (CPOE) systems reduce medication errors and adverse drug events (ADEs). The effect of CPOE implementation in a pediatric population has not been reported. The objective of this study was to evaluate the impact of CPOE on the frequency of errors in the medication ordering process in a pediatric critical care unit (PCCU).
Methods. A prospective trial was conducted of 514 pediatric patients who were admitted to a 20-bed PCCU in a tertiary-ethods.care children’s hospital before and after implementation of CPOE. Medication errors were identified after review of all orders during the study period and then further classified as potential ADEs, medication prescribing errors (MPE), and rule violations (RV).
Results. A total of 13 828 medication orders were reviewed. Before implementation, potential ADEs occurred at a rate of 2.2 per 100 orders, MPEs at a rate of 30.1 per 100 orders, and RVs at a rate of 6.8 per 100 orders. After implementation, the rate of potential ADEs was reduced to 1.3 per 100 orders, MPEs to 0.2 per 100 orders, and RVs to 0.1 per 100 orders. The overall error reduction was 95.9%. Potential ADEs were reduced by 40.9%, and MPEs and RVs were reduced by 99.4% and 97.9%, respectively.
Conclusions. The implementation of CPOE resulted in almost a complete elimination of MPEs and RVs and a significant but less dramatic effect on potential ADEs.

04 January 2004

Homeopathy: Why Does It Work?

Today, I was asked for biological evidence of the mechanism for homeopathy. Homeopathy clearly works as I use it regularly and get remarkable results. Homeopathy, nutritional supplements, and electronic medicine have allowed me to avoid all drugs and antibiotics for over a decade now. As a more detailed example, Dr. Ramakrishnan has published data on thousands of his cancer patients showing more data and better results than most oncologists in our leading medical centers can muster. See:

Ramakrishnan, A.U. and Coulter, Catherine R. (2001) A Homeopathic Approach to Cancer. Quality Medical Publishing.

But how does it work and what can we find in the leading medical journals? Answering this question will take multiple postings so lets start with a review of the literature:

Clinical trials of homoeopathy.
Kleijnen J, Knipschild P, ter Riet G.
BMJ. 1991 Feb 9;302(6772):316-23.

OBJECTIVE--To establish whether there is evidence of the efficacy of homoeopathy from controlled trials in humans.
DESIGN--Criteria based meta-analysis. Assessment of the methodological quality of 107 controlled trials in 96 published reports found after an extensive search. Trials were scored using a list of predefined criteria of good methodology, and the outcome of the trials was interpreted in relation to their quality.
SETTING--Controlled trials published world wide.
MAIN OUTCOME MEASURES--Results of the trials with the best methodological quality. Trials of classical homoeopathy and several modern varieties were considered separately.
RESULTS--In 14 trials some form of classical homoeopathy was tested and in 58 trials the same single homoeopathic treatment was given to patients with comparable conventional diagnosis. Combinations of several homoeopathic treatments were tested in 26 trials; isopathy was tested in nine trials. Most trials seemed to be of very low quality, but there were many exceptions. The results showed a positive trend regardless of the quality of the trial or the variety of homeopathy used. Overall, of the 105 trials with interpretable results, 81 trials indicated positive results whereas in 24 trials no positive effects of homoeopathy were found. The results of the review may be complicated by publication bias, especially in such a controversial subject as homoeopathy.
CONCLUSIONS--At the moment the evidence of clinical trials is positive but not sufficient to draw definitive conclusions because most trials are of low methodological quality and because of the unknown role of publication bias. This indicates that there is a legitimate case for further evaluation of homoeopathy, but only by means of well performed trials.

Keijnan and coworkers note that "the subject of the efficacy of homeopathy can hardly be tackled without providing some plausible explanation as to its mechanism of action." A good place to start studying this question is:

Bellavite, Paolo and Signorini, Andrea (1995) Homeopathy: A Frontier in Medical Science. North Atlantic Books.

Current research can only partly explain the phenomenon of homeopathy because the mechanism goes beyond the bounds of classical pharmacology. However, it has an interesting and remarkable connection to electronic medicine.

Physicists Show Homeopathic Effect

Any good homeopath can repeatedly product powerful effects with extremely dilute substances. The conventional scientific paradigm says that this cannot be true because there is no logical explanation for it. This "ostrich" effect is common in science and goes directly against the grain of the scientific method. If you set up a repeatable experiment that anyone can reproduce, the fact that you are ignorant of the mechanism does not disprove the experiment. It simply proves that your current conception of science is inadequate.

Icy claim that water has memory
19:00 11 June 03 Exclusive from New Scientist Print Edition

Claims do not come much more controversial than the idea that water might retain a memory of substances once dissolved in it. The notion is central to homeopathy, which treats patients with samples so dilute they are unlikely to contain a single molecule of the active compound, but it is generally ridiculed by scientists.

Holding such a heretical view famously cost one of France's top allergy researchers, Jacques Benveniste, his funding, labs and reputation after his findings were discredited in 1988.

Yet a paper is about to be published in the reputable journal Physica A claiming to show that even though they should be identical, the structure of hydrogen bonds in pure water is very different from that in homeopathic dilutions of salt solutions. Could it be time to take the "memory" of water seriously?

Rey L. Thermoluminescence of ultra-high dilutions of lithium chloride and sodium chloride. Physica A 2003, 323, 67-74.